首页> 外国专利> GENERATION OF OLIGODENDROGENIC NEURAL PROGENITOR CELLS

GENERATION OF OLIGODENDROGENIC NEURAL PROGENITOR CELLS

机译:少突胶质神经祖细胞的产生

摘要

Provided herein are methods of producing, compositions comprising and uses of oligodendrogenic neural progenitor cells (o-NPCs), made using a combination of PDGFR agonist and thyroxin or a thyroxin analogue. The method includes; obtaining ventralized neural progenitor cells (NPCs), the ventralized NPCs expressing Sox2, Nkx6-1, decreased level of Pax6 compared to unpatterned NPCs, and elevated expression of HoxA4 compared to unpatterned NPCs; culturing the ventralized NPCs for about 12 to about 16 days (days 26-40 of Fig. 7; days 12 to 27 of Fig. 10) in neural expansion media (NEM) supplemented with i) PDGFR agonist for the about 12 to about 16 days and ii) thyroxine or a thyroxine analogue for the latter about 7 to about 9 days, to produce o-NPC expressing Sox2 and Nkx2.2, decresed level of Pax6 and Nkx6.1 compared to ventralized NPCs and elevated level of HoxA4 and Olig2 compared to ventralized NPCs.
机译:本文提供了使用PDGFR激动剂和甲状腺素或甲状腺素类似物的组合制备的少突胶质神经祖细胞(o-NPC)的生产方法,组合物和用途。该方法包括:获得腹侧神经祖细胞(NPC),与无模式NPC相比,腹侧NPC表达Sox2,Nkx6-1,Pax6水平降低,HoxA4表达升高。在补充i)PDGFR激动剂约12至约16的神经膨胀培养基(NEM)中将腹侧NPC培养约12至约16天(图7第26-40天;图10第12至27天)。 ii)甲状腺素或甲状腺素类似物(大约7至9天),可产生表达Sox2和Nkx2.2的邻NPC,与腹腔NPC相比,Pax6和Nkx6.1的水平降低,而HoxA4和Olig2的水平升高与气腹NPC相比。

著录项

  • 公开/公告号WO2019023793A1

    专利类型

  • 公开/公告日2019-02-07

    原文格式PDF

  • 申请/专利权人 UNIVERSITY HEALTH NETWORK;

    申请/专利号WO2018CA50926

  • 发明设计人 FEHLINGS MICHAEL G.;KHAZAEI MOHAMAD;

    申请日2018-07-30

  • 分类号C12N5/0797;A61K35/30;A61P35;A61P25/28;

  • 国家 WO

  • 入库时间 2022-08-21 11:56:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号